The EXPRESS CALL TO FUND RESEARCH ON COVID-19 announced at the end of March, has just been concluded.
Dr hab. Ewelina Król from the Intercollegiate Faculty of Biotechnology UG and GUMed is one of the competition winners. She received PLN 999.600,00 in funding for the project:
“Towards safe anti-SARS-CoV-2 coronavirus vaccine - modifications of the spike protein leading to the elimination of ADE effect”.
The objective of the call was to select projects that would enhance understanding of the mechanisms of the SARS-CoV-2 coronavirus, as well as improving diagnostic tests, finding new drugs and mitigating the social and economic effects of the pandemic. Although it was an express call, the highest evaluation standards were adhered to. Researchers had only 2 weeks to submit their proposals and the two-stage evaluation was performed in just a month. Regardless of this short deadline for submitting proposals, the call attracted a lot attention – which is why it was decided to increase the original budget of PLN 10,000,000. Researchers submitted 262 proposals for a total amount of over PLN 140,000,000, of which 259 proposals were submitted for merit-based evaluation. Funding of over PLN 12,000,000 was awarded to 19 research projects.